| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/06/1997 | WO1997008551A1 Methods and antibodies for detecting creatine kinase |
| 03/06/1997 | WO1997008345A1 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
| 03/06/1997 | WO1997008335A1 Monoclonal antibody recognizing serum amyloid a |
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | WO1997008320A1 Protein/(poly)peptide libraries |
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | WO1997008301A1 Novel factors which modify gene transcription and methods of use therefor |
| 03/06/1997 | WO1997008205A1 Antibodies having two or more specificities for the selective elimination of cells in vivo |
| 03/06/1997 | WO1997008204A1 Methods for detection of cryptosporidium oocysts |
| 03/06/1997 | WO1997008203A1 Structural mimics of rgd-binding sites |
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | WO1997008192A1 Tricyclic antidepressant derivatives and conjugated useful in immunoassays |
| 03/06/1997 | WO1997008189A1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 03/06/1997 | WO1997008186A1 Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors |
| 03/06/1997 | WO1997007819A1 Immunotherapy medicaments containing antibodies which specifically detect the mhcii antigen of a patient to be treated |
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1997007671A1 Chimeric animal and method for constructing the same |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2230753A1 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2230052A1 Tricyclic antidepressant derivatives and conjugated useful in immunoassays |
| 03/06/1997 | CA2229043A1 Protein/(poly)peptide libraries |
| 03/06/1997 | CA2227963A1 Novel factors which modify gene transcription and methods of use therefor |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/06/1997 | CA2202907A1 Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors |
| 03/05/1997 | EP0760100A1 PHAGE/PHAGEMID DISPLAY LIBRARY COMPRISING RANDOMLY CLEAVED cDNA/GENOMIC DNA OR CLONED GENE |
| 03/05/1997 | EP0759997A1 Use of tetracycline promoter for the strictly regulated production of recombinant proteins in prokaryotic cells |
| 03/05/1997 | EP0759987A1 Human restrictin and nucleic acid sequences |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
| 03/05/1997 | EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759693A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
| 03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
| 03/05/1997 | EP0512087B1 Process for reactivating denatured protein |
| 03/04/1997 | US5608104 Quick analysis of pyrethroid compounds with antibodies |
| 03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
| 03/04/1997 | US5608037 Genetic engineering and proteins |
| 03/04/1997 | US5607916 Method and composition for the treatment of septic shock |
| 03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
| 03/04/1997 | US5607847 Cells, monoclonal antibodies and hybridomas |
| 03/04/1997 | US5607843 Dna for gene expression and proteins in cells |
| 03/04/1997 | US5607841 Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 03/04/1997 | US5607675 Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxin |
| 03/04/1997 | CA2067797C Production and use of human nm23 protein and antibodies therefor |
| 02/27/1997 | WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | WO1997007399A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/27/1997 | WO1997007398A1 Polypeptide-dendrimer complexes |
| 02/27/1997 | WO1997007225A2 High efficiency retroviral packaging system |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007215A1 Agonists of haemopoietic growth factors |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007204A1 Antibody 105a5 to 'peanut agglutinin' (pna)-binding glycoprotein on cell surfaces |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007136A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | WO1997007135A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007132A1 Epitope tagging system |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006823A1 Monoclonal antibodies for detecting norwalk virus |
| 02/27/1997 | WO1997006822A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 02/27/1997 | DE19531348A1 Antikörper mit zwei oder mehr Spezifitäten zur selektiven Eliminierung von Zellen in vivo Antibodies having two or more specificities for the selective elimination of cells in vivo |
| 02/27/1997 | DE19531346A1 Arzneimittel zur Immuntherapie, enthaltend Antikörper, die spezifisch das MHCII-Antigen eines zu behandelnden Patienten erkennen Drugs for immunotherapy, containing antibodies which specifically recognize the MHCII-antigen of a patient to be treated |
| 02/27/1997 | DE19531033A1 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine Antibodies against at surfaces of carcinoma cells outside exposed epitopes of desmosomal cadherins of desmosomes |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229540A1 Epitope tagging system |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229140A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/27/1997 | CA2201712A1 Polypeptide:dendrimer complexes |
| 02/26/1997 | EP0759470A2 Gene encoding endoglycoceramidase activator |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies |
| 02/26/1997 | EP0759302A1 Remedy for rheumatoid arthritis |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759071A1 Wt1 monoclonal antibodies and methods of use therefor |
| 02/26/1997 | EP0759068A1 $i(RPS2) GENE AND USES THEREOF |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |